News

CHAR Technologies Revamps Private Placement Strategy for Growth

CHAR Technologies Revamps Private Placement Strategy for Growth

CHAR Technologies Updates on Private Placement and Market Strategy

CHAR Technologies, a frontrunner in the field of sustainable energy, has recently announced a significant update regarding its private placement strategy. The company is excited to share the repricing of a previously disclosed private placement, aimed at fostering growth and enhancing operational capabilities.

Details of the Updated Offering

The latest offering will consist of up to 4,550,000 units priced at $CDN 0.22 per unit, projected to generate gross proceeds of approximately $CDN 1 million. This initiative reflects the positive market sentiment following the Government grant of $CDN 2.25 million. The enthusiasm around this grant has catalyzed the decision to adjust the pricing structure of the offering, aligning it with market expectations and investor confidence.

Institutional Interest and Subscription Status

The company is pleased to affirm that the offering remains fully subscribed with robust backing from institutional investors. Anticipated closing of this offering is projected around the end of the week, contingent upon the fulfillment of certain conditions, including obtaining all necessary approvals and acceptance from the TSX Venture Exchange.

Structure of the Offering

Each unit within the offering comprises one common share and a non-transferable purchase warrant, enabling holders to acquire an additional common share at a price of $CDN 0.32 for a period of 24 months post-closing. For this transaction, CHAR Technologies may consider compensating certain eligible finders, potentially including a cash commission up to 6% of the total gross proceeds.

Utilization of Proceeds

The proceeds from this private placement will be strategically allocated for general working capital and to advance project development efforts. This funding aims to propel CHAR’s ongoing project pipeline, ensuring sustained forward momentum within its operations and innovation processes.

Offering Regulations and Compliance

The units from this offering are being made available to purchasers outside of Canada, in accordance with exemptions under Ontario Securities Commission Rule 72-503. Consequently, these securities are not subject to resale restrictions under this framework. Furthermore, as defined by Multilateral Instrument 61-101, this offering does not represent a related party transaction, and thus is not bound by TSXV Policy 5.9.

About CHAR Technologies

CHAR Technologies, operating under the ticker TSXV:YES, specializes in advanced high temperature pyrolysis technology. The innovative processes developed by CHAR convert unmerchantable wood and organic waste into two significant renewable energy revenue streams: renewable natural gas (RNG) or green hydrogen, alongside producing biocarbon as a sustainable alternative for metallurgical coal. This dual revenue model distinctly positions CHAR Technologies at the forefront of waste-to-energy solutions, advocating for a greener transition and reduced carbon footprint.

Commitment to Sustainability

CHAR’s initiatives support the global shift toward green energy, effectively diverting waste from landfills while simultaneously generating clean energy. Through this commitment, CHAR Technologies aligns its operations with the objectives of decarbonizing heavy industries, aiming to foster a sustainable future.

Contact Information for Further Inquiries

For additional details, stakeholders and investors can reach out to CHAR Technologies directly. The team is open to engaging dialogues concerning this offering and company developments:

Andrew White
Chief Executive Officer
CHAR Technologies Ltd.
Email: andrew.white@chartechnologies.com
Phone: 866 521-3654

Galen Cranston
Director of Stakeholder Relations
CHAR Technologies Ltd.
Email: gcranston@chartechnologies.com
Phone: 647-546-5633

Website: www.chartechnologies.com

Frequently Asked Questions

What is the primary objective of the updated private placement?

The updated private placement aims to raise funds for working capital, support ongoing project development, and enable further growth initiatives within CHAR Technologies.

How much is CHAR Technologies aiming to raise through this offering?

The company is looking to raise approximately $CDN 1 million through the private placement offering.

What does each unit in the offering consist of?

Each unit consists of one common share and one non-transferable common share purchase warrant, offering additional growth potential to the investors.

Are there any restrictions on the resale of the securities?

No, the securities issued under this offering will not be subject to any resale restrictions, as they are offered outside of Canada under an exemption from the prospectus requirement.

What type of technology does CHAR Technologies specialize in?

CHAR Technologies specializes in high temperature pyrolysis technology, converting waste materials into renewable energy products, supporting sustainable and eco-friendly initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LONGi's Four Paths to Global Green Development

Updated Category News Views 62

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 149

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 469

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 92

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

AAVantgarde's Professor Auricchio Receives Prestigious Role

Updated Category News Views 177

AAVantgarde's Professor Auricchio Achieves New Milestone MILAN, a milestone moment has arrived for AAVantgarde Bio as Professor Alberto Auricchio, the visionary Founder and Chief Scientific Officer, has been elected President of the European Society of Gene and Cell Therapy. This prestigious appointment recognizes his exceptional contributions and unwavering commitment to...

Continue Reading
How Bitcoin's Drop Affects Strategy Inc (NASDAQ: MSTR) Investors

Updated Category News Views 137

Understanding the Current Market Landscape As recent market trends demonstrate, Strategy Inc (NASDAQ: MSTR) is seeing significant activity. On one hand, the company is evidently reliant on the performance of Bitcoin. With such dependence, the fluctuations in the value of Bitcoin are crucial to the health of MSTR. This situation poses both risks and opportunities for...

Continue Reading
Significant Attorney Departures to Strengthen Association Law Firm

Updated Category News Views 99

Major Attorney Moves to Association Law Group (ALG) In a noteworthy shift within Florida's community association law landscape, several prominent attorneys have transitioned from Becker & Poliakoff to join the ranks of Association Law Group (ALG). Among them, Michael C. Gongora, Lilliana Farinas-Sabogal, and Adam Cervera are recognized for their extensive experience in...

Continue Reading
EQB's Commitment to Sustainability in Financial Services

Updated Category News Views 175

EQB Focuses on Sustainability in Its Latest Report EQB Inc. (TSX: EQB) has recently published a detailed Responsibility Report, highlighting significant strides towards its sustainability commitments. This annual report encapsulates the company's dedication to fostering an environment of innovation within the Canadian banking sector, with a particular focus on enriching...

Continue Reading
BofA's Downgrade of Sandvik: Navigating Market Pressures Ahead

Updated Category News Views 103

BofA Securities dropped a bomb on Sandvik AB back then by downgrading it from Neutral to Underperform. This move sent shockwaves through the trading floor, mainly because they saw some serious trouble brewing in Sandvik’s Machining and Manufacturing Solutions (SMMS) division. Traders were quick to pick up on the whispers about short cycle pressures that could really...

Continue Reading